Fundies.
English

Addex Therapeutics Ltd.

EDGAR
ADXN Report (type unavailable) · filed 2026-10-08

Annual consolidated revenue for 2025: about Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 29.97K, using the latest reported figures. The previous period, 2024, was about Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 404.1K.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

115 thousand Unit_Standard_CHF_-CrtKA0d8EeNl84nhV359A

2024 Q2 · Unit_Standard_CHF_-CrtKA0d8EeNl84nhV359A

Exact inputs and evidence
  • Revenue: 115277 Unit_Standard_CHF_-CrtKA0d8EeNl84nhV359A Source
Cash and cash equivalents
767 thousand Unit_Standard_CHF_veB9_Q4q_kaAYWswP-S8rw Source
Exact value

767328 Unit_Standard_CHF_veB9_Q4q_kaAYWswP-S8rw

Long-term debt including current maturities
Not available
Shares outstanding
Not available

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-08.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2025-12-31
  • Operating income: 3 of 11 periods available· newest 2025-12-31
  • net income: No compatible figures in this window
  • Operating cash flow: 3 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2025-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • liabilities: No compatible figures in this window
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -92.6%

    Prior period

    Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 404,102

    –

    Current period

    Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 29,972

    –

    Exact inputs and evidence

    29972 − 404102 = -374130 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

    404102 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    29972 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 3.2 million

    Prior period

    −Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 5.37 million

    –

    Current period

    −Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 2.17 million

    –

    Exact inputs and evidence

    -2171117 − -5373554 = 3202437 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

    -5373554 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -2171117 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -100%

    Prior period

    Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 1,273

    –

    Current period

    Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 0

    –

    Exact inputs and evidence

    0 − 1273 = -1273 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

    1273 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    0 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 29,972 100% of revenue
  • Operating costs Derived Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 2.84 million 9,491% of revenue
  • Operating income −Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 2.81 million −9,391% of revenue
  • Tax, interest and other Derived Unavailable An input is unavailable.
  • Net income Unavailable An input is unavailable.

Cash

  • Operating cash flow −Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 2.17 million −7,244% of revenue
  • Capital expenditure Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 0 0% of revenue
  • Free cash flow Derived −Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 2.17 million −7,244% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2023 Not shown: operating income or net income is not reported.
  • 2024 Not shown: operating income or net income is not reported.
  • 2025 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2023 2023-01-01 – 2023-12-311612953 3855920 Derived -2242967 UnavailableUnavailable-7999253 Derived
Source
2024 2024-01-01 – 2024-12-31404102 3159335 Derived -2755233 UnavailableUnavailable-5374827 Derived
Source
2025 2025-01-01 – 2025-12-3129972 2844570 Derived -2814598 UnavailableUnavailable-2171117 Derived
Source

Amounts are exact, in Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 30K 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.7M1.3M871.0K435.5K0.0202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw)Source evidence
2023Revenue1612953
2024Revenue404102
2025Revenue29972

Revenue growth

Change in revenue from the same financial period one year earlier.

-92.6% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.7%-19%-46%-73%-100%202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2023Year over yearNo prior comparable period
2024Year over year-74.9%
2025Year over year-92.6%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -9,390.8% 2025
Free cash flow margin -7,243.8% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.751%-1,972%-4,695%-7,419%-10,142%202320242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2023Operating margin-139.1%
2024Operating margin-681.8%
2025Operating margin-9,390.8%
2023-12-31Net marginNot reported
2024-12-31Net marginNot reported
2025-12-31Net marginNot reported
2023Free cash flow margin-495.9%
2024Free cash flow margin-1,330.1%
2025Free cash flow margin-7,243.8%

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw -2.2M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.639.4K-1.7M-4.0M-6.3M-8.6M202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw)Source evidence
2023Operating cash flow-7992411
2024Operating cash flow-5373554
2025Operating cash flow-2171117

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw -2.2M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.639.9K-1.7M-4.0M-6.3M-8.6M202320242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw)Source evidence
2023Free cash flow-7999253
2024Free cash flow-5374827
2025Free cash flow-2171117

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2023-12-31Liabilities / assetsNot reportedNo source recorded
2024-12-31Liabilities / assetsNot reportedNo source recorded
2025-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2023-12-31Current assets / current liabilitiesNot reportedNo source recorded
2024-12-31Current assets / current liabilitiesNot reportedNo source recorded
2025-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2023 2023-01-01 – 2023-12-31
Unavailable Not reported for this period.
−Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 7.99 million
Exact value

Exact value: -7992411 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

2023-01-01 – 2023-12-31: -7992411 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 6,842
Exact value

Exact value: 6842 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

2023-01-01 – 2023-12-31: 6842 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 8 million
Calculation and evidence

-7992411 − 6842 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

Exact free cash flow: -7999253 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
Unavailable Not reported for this period.
−Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 5.37 million
Exact value

Exact value: -5373554 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

2024-01-01 – 2024-12-31: -5373554 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 1,273
Exact value

Exact value: 1273 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

2024-01-01 – 2024-12-31: 1273 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 5.37 million
Calculation and evidence

-5373554 − 1273 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

Exact free cash flow: -5374827 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
Unavailable Not reported for this period.
−Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 2.17 million
Exact value

Exact value: -2171117 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

2025-01-01 – 2025-12-31: -2171117 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 0
Exact value

Exact value: 0 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

2025-01-01 – 2025-12-31: 0 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw 2.17 million
Calculation and evidence

-2171117 − 0 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

Exact free cash flow: -2171117 Unit_Standard_CHF_vi4EfuoCFkKtCS4tww2Zlw

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

139 filings · 1,367 latest values · 1,367 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001574232, 1574232, ADXN, edgar:1574232

Also known as Addex Therapeutics Ltd, Addex Therapeutics Ltd.